E. Zor

Uptake of 2-[F]fluoro-2-deoxy-D-glucose in uterine leiomyoma: imaging of four patients by coincidence positron emission tomography

S. Özalp, E. Vardareli, I. Ak, 2004 .

F18-FDG coincidence-PET in patients with suspected gynecological malignancy

S. Özalp, M. Stokkel, E. Vardareli, 2006, Acta radiologica.

Ruxolitinib versus best available therapy in inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): 5-year follow up of a randomised, phase 3b study.

M. Griesshammer, P. Guglielmelli, A. Vannucchi, 2022, The Lancet. Haematology.

Cardiac and hepatic siderosis in myelodysplastic syndrome, thalassemia and diverse causes of transfusion-dependent anemia: the TIMES study

D. Bowden, R. Ramakrishna, O. Gervásio, 2019, HemaSphere.

Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study

F. Mannelli, A. Vannucchi, F. Passamonti, 2021, Leukemia.

Analysis of predictors of response to ruxolitinib in patients with myelofibrosis in the phase 3b expanded-access JUMP study

M. Griesshammer, P. Guglielmelli, H. Al-Ali, 2020, Leukemia & lymphoma.

Uptake of 2-[18F]fluoro-2-deoxy-D-glucose in uterine leiomyoma: imaging of four patients by coincidence positron emission tomography

S. Özalp, E. Vardareli, I. Ak, 2004, Nuclear medicine communications.